Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Human TDG Polyclonal Antibody

Catalog #:   PHG59101 Specific References (29) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: Q13569
Overview

Catalog No.

PHG59101

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human TDG (Ser115-Gly343).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

TDG, Thymine-DNA glycosylase, G/T mismatch-specific thymine DNA glycosylase, hTDG

Purification

Purified by antigen affinity column.

Accession

Q13569

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with TDG antibody (PHG59101) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 28 kDa
    Observed MW: 28 kDa
References

Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial., PMID:38701817

Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury., PMID:37821897

Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19., PMID:35895508

A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike., PMID:35273217

Comprehensive BCMA Expression Profiling in Adult Normal Human Brain Suggests a Low Risk of On-target Neurotoxicity in BCMA-targeting Multiple Myeloma Therapy., PMID:35193424

Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment., PMID:34484869

Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies., PMID:34290252

Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis., PMID:33253612

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19., PMID:32300051

Characterizing memory loss in patients with autoimmune limbic encephalitis hippocampal lesions., PMID:31472008

Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer., PMID:28848075

A prospective open-label study of sirolimus for the treatment of anti-Hu associated paraneoplastic neurological syndromes., PMID:24994790

Advances in understanding the coupling of DNA base modifying enzymes to processes involving base excision repair., PMID:23870509

Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics., PMID:23602152

50nm-scale localization of single unmodified, isotopically enriched, proteins in cells., PMID:23431383

T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment., PMID:22878899

Generation and replication-dependent dilution of 5fC and 5caC during mouse preimplantation development., PMID:22124233

Immunoregulatory effects of ethyl-acetate fraction of extracts from Tetrastigma hemsleyanum Diels et. Gilg on immune functions of ICR mice., PMID:18837297

[Uracil-DNA glycosylases]., PMID:19248582

Uracil in DNA--general mutagen, but normal intermediate in acquired immunity., PMID:17116429

The effect of galectin 1 on 3T3 cell proliferation on chitosan membranes., PMID:15020134

Prevalence of thyroid microsomal and thyroglobulin autoantibodies in goitrous lesions., PMID:11873391

[Anti-microsomal, anti-thyroglobulin antibodies and thyroid stimulants in hyperthyroid subjects. Analysis of 315 patients followed-up for 3 years at a single medical center]., PMID:7855385

Purification of factor XIa inhibitor from human platelets., PMID:1412206

Development and characterization of a polyclonal antibody against rat liver mitochondrial overt carnitine palmitoyltransferase (CPT I). Distinction of CPT I from CPT II and of isoforms of CPT I in different tissues., PMID:1546954

Thyroid carcinoma in thyrotoxic patients treated by surgery., PMID:3361079

Plasma membrane shedding and colloid vacuoles in hyperactive human thyroid tissue., PMID:2907207

Effects of thyroid stimulating immunoglobulin on function and morphology of xenotransplanted toxic diffuse, toxic nodular and normal thyroid tissue., PMID:2892875

Comparison and evaluation of different methods for alpha-MSH labelling., PMID:6757323

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human TDG Polyclonal Antibody [PHG59101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only